Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Harvard Bioscience Debt to Equity Ratio 2010-2023 | HBIO

Current and historical debt to equity ratio values for Harvard Bioscience (HBIO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Harvard Bioscience debt/equity for the three months ending December 31, 2023 was 0.42.
  
Harvard Bioscience Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.06B $0.07B 0.88
2023-09-30 $0.07B $0.07B 0.88
2023-06-30 $0.07B $0.08B 0.90
2023-03-31 $0.07B $0.07B 0.96
2022-12-31 $0.07B $0.07B 1.01
2022-09-30 $0.08B $0.07B 1.04
2022-06-30 $0.08B $0.08B 1.00
2022-03-31 $0.08B $0.08B 1.07
2021-12-31 $0.08B $0.08B 0.95
2021-09-30 $0.08B $0.08B 1.00
2021-06-30 $0.08B $0.08B 0.96
2021-03-31 $0.07B $0.08B 0.96
2020-12-31 $0.08B $0.08B 1.04
2020-09-30 $0.07B $0.08B 0.94
2020-06-30 $0.08B $0.08B 0.98
2020-03-31 $0.08B $0.08B 1.06
2019-12-31 $0.08B $0.08B 1.02
2019-09-30 $0.09B $0.08B 1.11
2019-06-30 $0.09B $0.08B 1.07
2019-03-31 $0.09B $0.08B 1.13
2018-12-31 $0.09B $0.08B 1.04
2018-09-30 $0.08B $0.08B 1.04
2018-06-30 $0.09B $0.08B 1.14
2018-03-31 $0.09B $0.08B 1.16
2017-12-31 $0.03B $0.08B 0.35
2017-09-30 $0.03B $0.08B 0.44
2017-06-30 $0.03B $0.08B 0.45
2017-03-31 $0.04B $0.07B 0.48
2016-12-31 $0.04B $0.07B 0.49
2016-09-30 $0.04B $0.08B 0.48
2016-06-30 $0.04B $0.08B 0.49
2016-03-31 $0.04B $0.08B 0.51
2015-12-31 $0.04B $0.08B 0.55
2015-09-30 $0.04B $0.09B 0.42
2015-06-30 $0.04B $0.10B 0.46
2015-03-31 $0.04B $0.09B 0.48
2014-12-31 $0.04B $0.10B 0.42
2014-09-30 $0.04B $0.10B 0.41
2014-06-30 $0.04B $0.10B 0.40
2014-03-31 $0.04B $0.10B 0.41
2013-12-31 $0.04B $0.09B 0.43
2013-09-30 $0.04B $0.11B 0.38
2013-06-30 $0.04B $0.11B 0.39
2013-03-31 $0.03B $0.10B 0.30
2012-12-31 $0.03B $0.10B 0.28
2012-09-30 $0.03B $0.10B 0.30
2012-06-30 $0.03B $0.10B 0.32
2012-03-31 $0.03B $0.10B 0.34
2011-12-31 $0.03B $0.10B 0.33
2011-09-30 $0.03B $0.10B 0.32
2011-06-30 $0.03B $0.10B 0.33
2011-03-31 $0.03B $0.09B 0.35
2010-12-31 $0.04B $0.09B 0.38
2010-09-30 $0.03B $0.09B 0.36
2010-06-30 $0.03B $0.08B 0.36
2010-03-31 $0.03B $0.08B 0.40
2009-12-31 $0.03B $0.08B 0.43
2009-09-30 $0.04B $0.07B 0.48
2009-06-30 $0.01B $0.07B 0.18
2009-03-31 $0.01B $0.07B 0.20
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.172B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $25.506B 31.32
Bruker (BRKR) United States $10.815B 30.45
Kewaunee Scientific (KEQU) United States $0.101B 11.88